| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/14/2013 | CN102604128B Preparation method for gelatin nanosphere |
| 08/14/2013 | CN102600148B Composition containing carbazole sulfonamide medicaments and preparation method of composition |
| 08/14/2013 | CN102585517B Hollow polyphosphazenes microsphere with magnetic particles embedded in casing layer and preparation method thereof |
| 08/14/2013 | CN102552934B Adriamycin nano-particles and preparation method thereof |
| 08/14/2013 | CN102552732B Chinese medicinal preparation or Chinese medicinal health care product with effect of reducing blood fat |
| 08/14/2013 | CN102552180B Clindamycin phosphate composition liensinine freeze-dried powder and preparation method thereof |
| 08/14/2013 | CN102552146B Epirubicin liposome as well as preparation method and preserving method thereof |
| 08/14/2013 | CN102526578B Granular medicine for treating cold |
| 08/14/2013 | CN102504215B Block copolymers and preparation method thereof |
| 08/14/2013 | CN102488663B Drug combination containing ethylenediamine diaceturate and preparing method thereof |
| 08/14/2013 | CN102462687B Pharmaceutical composition containing GC-20 |
| 08/14/2013 | CN102430028B Chinese medicinal patch for treating polycystic ovary syndrome and preparation method thereof |
| 08/14/2013 | CN102397558B Positioning pegylation modified compound of Exendin-4 analog and application thereof |
| 08/14/2013 | CN102387792B 固体制剂 Solid preparations |
| 08/14/2013 | CN102335197B Disinfector of skin and mucous membranes for inactivating viruses |
| 08/14/2013 | CN102309461B Pyridostigmine bromide odor masking dispersible tablets and preparation method thereof |
| 08/14/2013 | CN102105134B Stable injectable oil-in-water docetaxel nanoemulsion |
| 08/14/2013 | CN102091272B Black plaster product for bone fracture and preparation method thereof |
| 08/14/2013 | CN102085197B Venlafaxine slow-release preparation and preparation method thereof |
| 08/14/2013 | CN102026623B Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
| 08/14/2013 | CN101983054B Orally rapidly disintegrating tablet comprising imidafenacin |
| 08/14/2013 | CN101966157B Decitabine sustained release microsphere and preparation method thereof |
| 08/14/2013 | CN101955543B Nerve growth factor bound with laminin, and coding gene and application thereof |
| 08/14/2013 | CN101897754B Preparation method of polyethylene glycol 12-hydroxy stearate-containing danshen root medicament injection preparation |
| 08/14/2013 | CN101700401B Polyalkylene glycol with moiety for conjugating biologicallyactive compound |
| 08/14/2013 | CN101695501B Chitosan entrapment body of nano-scale arsenous acid and manufacturing method thereof |
| 08/14/2013 | CN101467985B Bisoprolol fumarate dispersible tablet and preparation method thereof |
| 08/14/2013 | CN101283991B Orally-disintegrating tablet and manufacturing method thereof |
| 08/13/2013 | US8507710 Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals |
| 08/13/2013 | US8507606 Biocomposite materials and methods for making the same |
| 08/13/2013 | US8507563 Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a process for producing the same |
| 08/13/2013 | US8507462 Compositions and uses thereof |
| 08/13/2013 | US8507439 Neuroprotective and neurorestorative method and compositions |
| 08/13/2013 | US8507430 Methods for administering FGF18 |
| 08/13/2013 | US8507277 Nonviral vectors for delivering polynucleotides |
| 08/13/2013 | US8507018 Foods, drug containing cocoa and proanthocyanidin; adjust concentration of nitrogen oxide; hypotensive agents; cardiovascular disorders |
| 08/13/2013 | US8507003 Compressed tablets comprising microcapsules with modified release |
| 08/13/2013 | US8506992 Percutaneous absorption-type pharmaceutical preparations |
| 08/13/2013 | US8506991 Nicotine transdermal preparation and production method thereof |
| 08/13/2013 | US8506945 Polymers with structure-defined functions |
| 08/13/2013 | CA2630399C Production of conjugates |
| 08/13/2013 | CA2592827C Methods for enhancing the quality of life of a growing animal |
| 08/13/2013 | CA2592474C Prostaglandin f2.alpha. derivative-containing product |
| 08/13/2013 | CA2570976C Methods of treatment of endobronchial infections |
| 08/13/2013 | CA2567830C Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight |
| 08/13/2013 | CA2564674C Drying process for preserving an active agent as a highly viscous liquid |
| 08/13/2013 | CA2562784C Fluorocarbon antigen delivery vectors and constructs |
| 08/13/2013 | CA2504021C Compositions and methods for transdermal oxybutynin therapy |
| 08/13/2013 | CA2477236C Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders |
| 08/13/2013 | CA2438513C Modified anti-egfr antibodies with reduced immunogenicity |
| 08/13/2013 | CA2433316C Molecular antigen array |
| 08/13/2013 | CA2410224C Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 08/13/2013 | CA2330741C Methods of forming protein-linked lipidic microparticles, and compositions thereof |
| 08/13/2013 | CA2312512C Directly compressible starch as enhancer of properties of excipients when used as binder and disintegrant for compression tablets |
| 08/08/2013 | WO2013115965A1 Polymer-agent conjugates, particles, compositions, and related methods of use |
| 08/08/2013 | WO2013115844A1 Compositions and methods for treatment of glaucoma |
| 08/08/2013 | WO2013115746A1 A production method for (effervescent) pharmaceutical compositions comprising an alpha - glucosidase inhibitor (miglitol) and metformin |
| 08/08/2013 | WO2013115745A1 A process for production of pharmaceutical (effervescent) composition comprising alpha - glucosidase inhibitor (e.g. vogliobose and metformin) |
| 08/08/2013 | WO2013115744A1 A process for production of pharmaceutical (effervescent) composition comprising alpha - glucosidase inhibitor (e.g. vogliobose and metformin) |
| 08/08/2013 | WO2013115743A1 Effervescent tablet formulations comprising the combination of voglibose and metformin |
| 08/08/2013 | WO2013114416A1 Lyophilized tablets of escitalopram oxalate for sublingual administration |
| 08/08/2013 | WO2013114231A1 Treated apertures |
| 08/08/2013 | WO2013113820A1 Antibody-containing sustained-release formulation for ocular administration |
| 08/08/2013 | WO2013113774A1 Factor xii inhibitors for the treatment of neurological inflammatory disorders |
| 08/08/2013 | WO2013113767A1 Method for administration of a probiotic |
| 08/08/2013 | WO2013113736A1 Pharmaceutical composition comprising a polymeric carrier cargo complex and an antigen |
| 08/08/2013 | WO2013113503A1 Conjugates of hydroxyalkyl starch and an oligonucleotide |
| 08/08/2013 | WO2013113502A1 Negatively charged nucleic acid comprising complexes for immunostimulation |
| 08/08/2013 | WO2013113501A1 Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or pepide antigen |
| 08/08/2013 | WO2013113326A1 Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen |
| 08/08/2013 | WO2013113325A1 Negatively charged nucleic acid comprising complexes for immunostimulation |
| 08/08/2013 | WO2013113130A1 Electrode sensor kit, electrode assembly, and topical preparation for establishing electrical contact with skin, use thereof, and method of electro-impedance tomography (eit) imaging using these |
| 08/08/2013 | WO2013090293A4 Methods and compositions for cancer therapy using mutant light molecules with increased affinity to receptors |
| 08/08/2013 | WO2013089394A3 Composition of an aqueous solution of polymeric nanoparticles and method for preparing same |
| 08/08/2013 | WO2013072813A3 Cytotoxic peptides and antibody drug conjugates thereof |
| 08/08/2013 | WO2012094620A8 Hydrophobic molecule-induced branched polymer aggregates and their use |
| 08/08/2013 | WO2012090070A8 Biodegradable drug delivery compositions |
| 08/08/2013 | US20130204192 Fragmented polymeric compositions and methods for their use |
| 08/08/2013 | US20130203982 Cellulose interpolymers and method of oxidation |
| 08/08/2013 | US20130203868 Composition for enteric hard capsules, and enteric hard capsule prepared using the composition |
| 08/08/2013 | US20130203863 Method for preparing a composition including a compound containing vanillin and ethylvanillin, composition thus obtained and use thereof |
| 08/08/2013 | US20130203857 Pharmaceutical Compositions for the Treatment of Bacterial Infections |
| 08/08/2013 | US20130203828 Pharmaceutical compositions comprising poh derivatives |
| 08/08/2013 | US20130203823 Stable topical compositions for 1,2,4-thiadiazole derivatives |
| 08/08/2013 | US20130203813 Medical devices having homogeneous charge density and methods for making same |
| 08/08/2013 | US20130203812 Ionic silicone hydrogels comprising pharmaceutical and/or nutriceutical components and having improved hydrolytic stability |
| 08/08/2013 | US20130203713 Polymeric biomaterials derived from phenolic monomers and their medical uses |
| 08/08/2013 | US20130203700 Cyclodextrin-based polymers for therapeutics delivery |
| 08/08/2013 | US20130203698 Aqueous iron carbohydrate complexes, their production and medicaments containing them |
| 08/08/2013 | US20130203680 Folate conjugates for treating inflammation of the eye |
| 08/08/2013 | US20130203675 Asymmetric biofunctional silyl monomers and particles thereof as prodrugs and delivery vehicles for pharmaceutical, chemical and biological agents |
| 08/08/2013 | US20130203665 Single-chain insulin agonists exhibiting high activity at the insulin receptor |
| 08/08/2013 | US20130203647 Delivery of hydrophilic peptides |
| 08/08/2013 | US20130202709 Methods of treatment of pancreatic cancer |
| 08/08/2013 | US20130202683 Topical formulations having enhanced bioavailability |
| 08/08/2013 | US20130202679 Targeted Particles Comprising Landscape Phage Fusion Proteins and Heterologous Nucleic Acid |
| 08/08/2013 | US20130202659 Polymer-agent conjugates, particles, compositions, and related methods of use |
| 08/08/2013 | US20130202652 Methods and compositions for delivery of active agents |
| 08/08/2013 | US20130202651 Composite vaccine adjuvant |
| 08/08/2013 | US20130202650 Topical composition comprising a combination of at least two penetration enhancing agents |